Home » Topics » BioWorld Science

BioWorld Science
RSS

Fujifilm patents HDAC6 inhibitors

Oct. 22, 2021

Targeting GSDMD-mediated pyroptosis as therapeutic strategy for endometriosis

Oct. 22, 2021

BUD13 identified as candidate gene in specific language impairment

Oct. 22, 2021

ARID1A is a marker of endometriosis progression

Oct. 22, 2021

Uncovering the roles of enteric glial cells in intestinal homeostasis, immunity and tissue repair

Oct. 22, 2021

Mablink and Emergence enter licensing agreement for ADC targeting Nectin-4

Oct. 21, 2021

Oncodesign and TiumBio collaborate to discover and develop candidates for fibrosis

Oct. 21, 2021

HLA fine mapping identifies INPP5A as a risk gene for tuberculosis

Oct. 21, 2021

Tango Therapeutics' MTAPnull PRMT5 inhibitor TNG-908 active in multiple xenograft tumor models

Oct. 21, 2021

NPAS3 identified as a risk gene for autism spectrum disorder

Oct. 21, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...